Anticoagulants Market | Business Growth, Development Factors, Current and Future Trends till 2029
Aimed at strategic decision-makers, this report explores current opportunities, emerging trends, and market dynamics shaping the anticoagulants sector.
Anticoagulants Market Analysis & Forecast: 2025-2029
The anticoagulants market size has grown strongly in recent years. It will grow from $49.33 billion in 2024 to $53.88 billion in 2025 at a compound annual growth rate (CAGR) of 9.2%. The growth in the historic period can be attributed to aging population, increased prevalence of cardiovascular diseases, rising awareness aboutThe importance of anticoagulantTherapy, expansion of indications for anticoagulant use, increased incidence of venous thromboembolism (VTE) and atrial fibrillation.
The anticoagulants market size is expected to see rapid growth in the next few years. It will grow to $85.87 billion in 2029 at a compound annual growth rate (CAGR) of 12.4%. The growth in the forecast period can be attributed to expansion of indications for novel anticoagulant drugs, rising healthcare expenditure, emergence of novel oral anticoagulants (NOACs) as primary treatment options, financial support offered by central authorities to revamp healthcare facilities, expansion of the healthcare infrastructure. Major trends in the forecast period include advancements in medical technologies and diagnostic methods, integration of artificial intelligence and data analytics in anticoagulant therapy, growing emphasis on patient education and adherence programs, development of reversal agents.
Get your free sample today:
Anticoagulants Market Drivers, growth And Outlook Report 2025 Sample
What Are The Factors Driving The Anticoagulants Market?
The increasing cardiovascular diseases are a key factor driving the growth of the anticoagulants market over the coming years. CVDs (cardiovascular diseases) are a category of heart and blood vessel problems. Cardiovascular diseases (CVDs) are the primary, source of death worldwide with low- and middle-income nations accounting for three-quarters of CVD deaths. Anticoagulation pharmacotherapy known as direct oral anticoagulants is used to minimize thrombosis in a variety of cardiovascular situations. For instance, in May 2024, according to the Centers for Disease Control and Prevention (CDC), a US-based government agency, in the United States there were 702,880 deaths attributed to heart disease in 2022, with 371,506 of those resulting from coronary artery disease. Additionally, approximately 805,000 individuals experience a heart attack each year in the country. Therefore, the increasing number of cardiovascular diseases drive the growth of the anticoagulants market.
What Segments Are Covered In The Anticoagulants Market Report?
The anticoagulants market covered in this report is segmented –
1) By Drug Class: Factor Xa Inhibitor, Heparin And LMWH, Vitamin K Antagonist, Other Drug Classes
2) By Route Of Administration: Oral Anticoagulant, Injectable Anticoagulant
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
4) By Application: Venous Thromboembolism, Atrial Fibrillation Or Flutter, Coronary Artery Disease, Other Applications
5) By End User: Hospitals, Homecare, Specialty Centers, Other End-Users
Subsegments:
1) By Factor Xa Inhibitor: Rivaroxaban, Apixaban, Edoxaban, Betrixaban
2) By Heparin And LMWH (Low Molecular Weight Heparin): Unfractionated Heparin, Enoxaparin, Dalteparin, Tinzaparin
3) By Vitamin K Antagonist: Warfarin, Acenocoumarol, Phenprocoumon
4) By Other Drug Classes: Direct Thrombin Inhibitors, Antiplatelet Agents, Novel Oral Anticoagulants (NOACs)
What Are The Main Trends, Positively Impacting The Growth Of Anticoagulants Market?
Major companies operating in the anticoagulants market are focusing on developing innovative solutions such as factor Xa inhibitor tests to meet the growing demand for testing due to the increased use of direct oral anticoagulants for stroke prevention and other serious cardiovascular conditions. Factor Xa Inhibitor Tests are assessments designed to evaluate the effectiveness and safety of anticoagulant medications that selectively inhibit factor Xa, thereby preventing blood clot formation in various medical conditions. For instance, in February 2024, F. Hoffmann-La Roche Ltd., a Switzerland-based biotechnology company, launched apixaban, edoxaban, and rivaroxaban coagulation tests. These newly launched coagulation tests for Factor Xa inhibitors utilize Roche's innovative reagent cassette concept, ensuring high-quality results and efficient sample processing while also providing standardization and automation for better workflow in laboratories. These tests are significant as they support clinical decision-making in patients using direct oral anticoagulants for stroke prevention, addressing the rising global demand for effective diagnostics in managing serious conditions like coronary artery disease and peripheral arterial disease.
Which Are The Major Players Operating In The Global Anticoagulants Market?
Major companies operating in the anticoagulants market include GlaxoSmithKline plc, Leo Pharma A/S, Alexion Pharmaceuticals Inc., Amphastar Pharmaceuticals Inc., Bayer AG, Boehringer Ingelheim International GmbH, Daiichi Sankyo Company Limited, Eisai Co. Ltd., Mylan N. V., Otsuka Holdings Co. Ltd., Pfizer Inc., Sanofi S. A., Apotex Inc., Aspen Pharmacare Holdings Limited, AstraZeneca plc, Bristol-Myers Squibb Company, CSL Behring, Dr. Reddy's Laboratories Ltd., Eli Lilly and Company, Fresenius Kabi AG, Hikma Pharmaceuticals plc, Johnson & Johnson, Lupin Limited, Mitsubishi Tanabe Pharma Corporation, Natco Pharma Limited, Novartis International AG, Portola Pharmaceuticals Inc., Strides Pharma Science Limited, Sun Pharmaceutical Industries Limited, Teva Pharmaceutical Industries Limited, Torrent Pharmaceuticals Limited, Zydus Cadila Healthcare Limited
View the full anticoagulants market report here:
Anticoagulants Market Drivers, growth And Outlook Report 2025
Anticoagulants Market Regional Insights:
North America was the largest region in the anticoagulants market in 2024. The regions covered in the anticoagulants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
#Contact Us:#
The Business Research Company
Market Research Reports
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info
#Follow Us On:#
LinkedIn: The Business Research Company | LinkedIn
Comments
Post a Comment